Drug details
Avsola (infliximab-axxq for injection)
type of DMARDs, TNF Inhibitors, Monoclonal Antibodies
Avsola (infliximab-axxq) is a tumor necrosis factor (TNF) blocker indicated for Crohn's disease, pediatric Crohn's disease, ulcerative colitis, pediatric ulcerative colitis, rheumatoid arthritis in combination with methotrexate, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
The drug is often used to treat Ankylosing spondylitis , Psoriatic arthritis , Ulcerative colitis .
This drug may have the following side effects:
- rash,
- diarrhea,
- joint pain,
- headache,
- itching
- coughing,
- fatigue,
- abdominal pain,
- fever,
- infusion-related reactions,
- high blood pressure (hypertension),
- indigestion/heartburn,
- infections (e.g., upper respiratory, sinusitis, pharyngitis, bronchitis),
- urinary tract infection (UTI),
- oral thrush/vaginal yeast infection, and
The following drugs are related to Avsola, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Imraldi (adalimumab-xxxx injection, for subcutaneous use)
- Asacol (mesalamine delayed-release tablets)
- Asacol HD (mesalamine delayed-release tablets, oral)
- Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
- Cimzia (certolizumab pegol injection)
- Cipro (ciprofloxacin)
- Cipro I.V. (ciprofloxacin iv)
- Cipro XR (ciprofloxacin extended-release)
- Ciprodex (ciprofloxacin and dexamethasone)
- Delzicol (mesalamine delayed-release capsules)
- Sotyktu (deucravacitinib tablets)
- Entyvio (vedolizumab for injection, for intravenous use)
- Flagyl (metronidazole)
- Flagyl ER (metronidazole extended release tablets)
- Flagyl Injection (metronidazole injection)
- Remicade (infliximab)
- Trexall (methotrexate)
- Tysabri (natalizumab)
- Zoryve (roflumilast cream)
- Stelara Injection (ustekinumab)